The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide

Chunkyu Ko, Woo Jin Park, Sanghyun Park, Seungtaek Kim, Marc P. Windisch, Wang Shick Ryu

Research output: Contribution to journalArticlepeer-review

39 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide'. Together they form a unique fingerprint.

Medicine & Life Sciences